Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-23-001159
Filing Date
2023-02-27
Accepted
2023-02-27 16:01:21
Documents
5
Period of Report
2023-03-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT aclarion_def14a.htm DEF 14A 174530
2 GRAPHIC image_003.jpg GRAPHIC 2708
3 GRAPHIC image_004.jpg GRAPHIC 811
4 GRAPHIC image_009.jpg GRAPHIC 1270
5 GRAPHIC image_010.jpg GRAPHIC 1305
  Complete submission text file 0001683168-23-001159.txt   184555
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41358 | Film No.: 23674634
SIC: 8071 Services-Medical Laboratories